Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-030-6 | CAS number: 917-61-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction: other studies
Administrative data
- Endpoint:
- toxicity to reproduction: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1981
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: public available study (non GLP, non guideline) Read across to sodium cyanate. For justification of read across see endpoint summary.
Data source
Reference
- Reference Type:
- publication
- Title:
- High oxygen affinity of maternal blood reduced fetal weight in rats
- Author:
- Bauer, C.; Jelkmann, W. and Moll, W.
- Year:
- 1 981
- Bibliographic source:
- Respiration Physiology (1981) 43, 169-178
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Public available literature. No guideline indicated. For details on method see materials and methods section.
- GLP compliance:
- not specified
- Type of method:
- in vivo
Test material
- Reference substance name:
- Sodium cyanate
- EC Number:
- 213-030-6
- EC Name:
- Sodium cyanate
- Cas Number:
- 917-61-3
- Molecular formula:
- CNO.Na
- IUPAC Name:
- sodium cyanate
- Details on test material:
- Source: Merck, Darmstadt, Germany
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Rats of the Sprague-Dawley strain weighing about 250 g were obtained from an animal breeding farm (Dr. Ivanovas, Kislegg, Germany). The rats were kept in animal house of the University under standard conditions (12 h light-dark cycle starting at 7 a.m., food: Altromin-R10 standard pellets and tap water ad libitum).
Administration / exposure
- Route of administration:
- other: exchange transfusion
- Vehicle:
- water
- Details on exposure:
- On day 19 of gestation pregnant animals were anesthetized and the blood was exchanged from female rats previously treated with sodium cyanate (exchange transfusion).
Female rats which served as blood donors for the exchange transfusion experiments received drinking water that contained either 0.5 g/dL sodium cyanate or water with the equivalent concentration of sodium as sodium chlorite for a period of 14 days. - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- no analytical verification of doses.
- Duration of treatment / exposure:
- Female rats which served as blood donors for the exchange transfusion experiments received drinking water that contained either 0.5 g/dL sodium cyanate or water with the equivalent concentration of sodium as sodium chlorite for a period of 14 days. Three days before the blood was drawn, the animals were allowed to drink normal tap water again.
On day 19 of gestation pregnant animals were anesthetized and the blood was exchanged from female rats previously treated with sodium cyanate (exchange transfusion). On day 21 of gestation the animals were sacrificed. - Frequency of treatment:
- blood donors: continuously via the drinking water
- Duration of test:
- blood donors: 14 days
maternal animals: 21 days of gestation
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 5 mg/L
Basis:
nominal in water
- No. of animals per sex per dose:
- not indicated.
- Control animals:
- yes
- Details on study design:
- Mating:
Virgin female rats were made pregnant by mating them between 8 a.m. and 10 a.m. in a ratio of one female to one male rat. This procedure yielded only a relative small percentage of pregnant animals (about 30 %) but has the advantage that the error in estimating the gestational age is only +/- 1h or less, which is important in view of the fast growth rate of rat fetuses. The day of mating was considered day zero of gestation.
Examinations:
On day 21 of gestation the animals were sacrificed. The abdomen was quickly opened and the weights of the fetus and the placenta after removing the umbilical vessels, of the fetal brain and the fetal liver were measured. The hematocrit of fetal blood was determined after puncturing the fetal heart. The oxygen concentration, oxygen capacity and P50 of the blood was determined. In addition hemoglobin and total protein concentration of the blood were measured. - Statistics:
- Mean values were tested for significant difference using Student's t-test. It was ascertained that all single values were within the limit of mean +/- 3 SD which indicated normal distribution. Differences were considered significant at a level of p =< 0.01.
Results and discussion
Effect levels
- Key result
- Dose descriptor:
- LOAEL
- Effect level:
- 5 mg/L drinking water
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: Fetus body weight
Observed effects
Exchange transfusion per se did not affect the fetuses: in the animals where exchange transfusion was done with normal blood, non of the fetus parameters measured differed significantly from those in the unmanipulated animals. However, exchange transfusion with cyanate blood led to a significant reduction of fetal body weight and liver weight whilst the weight of the fetal brain and the weight of the placenta were not changed. It should be noted that both in the cyanate and the control group, all fetuses were found alive at the time of the operation on day 21. Therefore, fetal survival in utero was not affected by the acute rise in oxygen affinity of the maternal blood.
Applicant's summary and conclusion
- Conclusions:
- The increase in oxygen affinity produced by exchange transfusing of pregnant rats on day 19 of gestation with blood that had been treated previously with sodium cyanate caused reduction of fetal body and liver weight.
- Executive summary:
The effects of an acute increase of the oxygen affinity of maternal blood in pregnant rats on fetal weight, fetal brain and liver weights, placental weight and the hematocrit of the fetal blood were examined. The increase in oxygen affinity was produced by exchange transfusing of pregnant rats on day 19 of gestation with blood that had been treated and modified previously with sodium cyanate. As a result of the exchange transfusion, the difference in oxygen affinity between maternal and fetal blood essentially disappeared causing an artificial situation. Pregnant rats exchanged with normal blood served as controls. On day 21 of gestation, the fetal body weight and the fetal liver weight were significantly smaller by 18% and 25% respectively, in the group where the oxygen affinity of the maternal blood was acutely raised when compared to the controls causing a lower support of the pups with oxygen. Also, the hematocrit of the fetal blood was significantly higher in the group where mothers had the high blood oxygen affinity. Placental weight and fetal brain weight were not significantly altered. The authors infer, that the reduction of fetal weight is due to fetal hypoxia which is caused by the abolishment of the difference in oxygen affinity between maternal and fetal blood, cause by sodium cyanate.
This study is not considered relevant for the hazard assessment of cyanate as effects were noted only secondary due to hemoglobin damage of parental animals and due to the artificial test conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.